F8687
胎牛血清
Australia origin, γ-irradiated, sterile-filtered, suitable for cell culture, suitable for hybridoma
别名:
胎牛血清, FBS, FCS, 血清
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
UNSPSC Code:
12352207
MDL number:
Biological source:
bovine fetus
Origin:
Australia origin
Sterility:
γ-irradiated, sterile-filtered
Shipped in:
dry ice
biological source
bovine fetus
Quality Level
sterility
γ-irradiated, sterile-filtered
product line
FBS Classic
composition
hemoglobin, ≤0.18 mg/mL
origin
Australia origin
technique(s)
cell culture | hybridoma: suitable, cell culture | mammalian: suitable
impurities
≤5 EU/mL endotoxin
shipped in
dry ice
storage temp.
−20°C
Application
胎牛血清已用于Roswell Park memorial institute培养基-1640 (RPMI-1640)，以培养骨髓瘤细胞系，RPMI-8226和U-266。它也被用作Dulbecco改性Eagle培养基(DMEM)的补充物，用于培养人脐静脉内皮细胞(HUVEC)和293 T细胞。
Biochem/physiol Actions
胎牛血清（FBS）由于其高营养成分，是用于补充细胞培养基的最常见的血清。FBS虽然蛋白质含量低，但对促进和维持脊椎动物、哺乳动物和昆虫细胞的生长很有效。它可以作为胚胎干细胞培养的补充物。FBS也可用于制备喂料层和条件介质。
Analysis Note
- 内毒素和血红蛋白测试
Other Notes
Still not finding the right product?
Explore all of our products under 胎牛血清
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
商品
Review the basics of using fetal bovine (or calf) serum for cell culture and how sourcing and regulations affect the price of sera for cell-based assays.
回顾使用胎牛（或小牛）血清进行细胞培养的基础知识，以及采购和法规如何影响细胞测定所用血清的价格。
默克提供血清产品，为您提供高品质澳大利亚胎牛血清和小牛血清现货和解决方案。牛血清由于包含丰富的营养成分，通常被添加到细胞培养液中，用于促进和维持脊椎动物，牛血清的来源地很多，其中澳大利亚来源的牛血清被公认为是品质更优。
Yan Zhang et al.
Artificial cells, nanomedicine, and biotechnology, 48(1), 60-67 (2019-12-20)
Background: Colon cancer is the most frequently lethal cancer in digestive system. Herein, we tested the influences of UNC5B antisense lncRNA 1 (UNC5B-AS1) on colon cancer cell growth and metastasis, along with the regulatory function of UNC5B-AS1 in microRNA-622 (miR-622)
Isolation and maintenance of avian ES cells
Petitte JN
Handbook of Stem Cells, 471-477 (2004)
Peng Zhang et al.
International journal of stem cells, 14(2), 229-239 (2021-02-27)
Implantation of bone marrow-derived mesenchymal stem cells (BMSCs) has been recognized as an effective therapy for attenuating acute lung injury (ALI). This study aims to discover microRNA (miRNA)-mediated improvement of BMSCs-based therapeutic effects. Mice were treated with lipopolysaccharide (LPS) for